VERO Biotech
1 known investors
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
BiotechHealthtechMedical Devices
Investors · 1
In the news
- VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery Systemprnewswire.com · 2023
- VERO Biotech Receives Funding from MVM Partners to Accelerate Growthprnewswire.com · 2021
- MVM invests in Vero Biotech - MVM Partners LLPmvm.com · 2021
- VERO Biotech Secures $50 Million Funding from Runway Growth Capitalprnewswire.com · 2021